Position in CRMD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$123,464
+$16,671 QoQ
Shares Held
15,728
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#126
of 194 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hayek Kallen Investment Management holds $245,476 across 2 Biotechnology names. CRMD ranks #1 (50.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRMD |
CorMedix Inc.
This page
|
15,728 | $123,464 | |
| 2 | AVXL |
Anavex Life Sciences Corp.
|
47,109 | $122,012 |
All Filings in CRMD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,464 | 15,728 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $106,793 | 15,728 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $342,422 | 29,443 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||